期刊文献+

替硝唑-聚癸二酸酐控释制剂的制备及释放 被引量:1

Preparation and drug release of the tinidazole-poly(sebacic anhydride) controlled-releasing preparations
下载PDF
导出
摘要 目的:采用HPLC法测定替硝唑-聚癸二酸酐控释制剂的含量,并研究其释药特性。方法:色谱条件为色谱柱:ShimPackVp-ODS柱(250mm×4.6mm,5μm);柱温:室温;流动相:甲醇-水(20:80);流速:1mL·min^-1;检测波长:310nm;进样量:10μL。将替硝唑-聚癸二酸酐控释制剂置于0.1mol·L^-1,pH7.4的磷酸缓冲液(PBS)中,37℃恒温振荡,每24h更换一次缓冲液,测定并计算缓冲液中药物浓度及药物累计释放百分率。结果:替硝唑含量在5.0~100.0mg·L^-1范围内,浓度与吸收度之间线性关系良好(r=0.9999);样品的平均回收率为101.84%,RSD为0.54%(n=4)。释药结果表明,聚癸二酸酐对替硝唑的释放呈一级释放动力学特征,拟合方程:Y=8.0583+34.4558t-3.1925t^2。结论:该方法灵敏,专属,准确,操作简便,可供该制剂的含量测定。 OBJECTIVE To develop an HPLC method for the determination of tinidazole-poly (sebacic anhydride) controlled-releasing preparations, and study the drug release characteristic. METHODS Chromatographic conditions included column: Shim-Pack VPODS ( 150 mm×4. 6 mm); column temperature: room temperature; mobilephase: methanol-water(20 : 80) ; flowrate: 1 mL. min^-1 detector: UV 310 nm; injection volume: 10μL. Tinidazole-Poly(sebacic anhydride) controlled-releasing preparations were put in 0. 1 mol·L^-1, pH 7. 4 PBS, vibrating at 37℃. The buffer was changed once in every 24 h, and was determinated and calculated drug concentration and cumulative release percent. RESULTS The calibration curve was linear (r= 0. 999 9) in the range of 5.0 - 100.0 mg·L^-1 for tinidazole, the mean recovery was 101. 84%, with RSD of 0. 539 40% (n = 4). The results of drug release demonstrated that the tinidazole-poly (sebacic anhydride) controlled-releasing preparations followed first order release kinetics, the regression equation was Y= 8, 058 33 + 34. 455 83t- 3. 192 5 t^2. CONCLUSION The method is sensitive, specific, accurate, simple and was suitable for the determination of tinidazole preparations.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2006年第7期794-796,共3页 Chinese Journal of Hospital Pharmacy
基金 河北省教育厅基金资助项目(编号:2004423)
关键词 替硝唑 聚癸二酸酐 高效液相法 控释 释药特性 tinidazole Poly (sebacic anhydride) HPLC controlled-releasing drug release characteristic
  • 相关文献

参考文献4

二级参考文献24

  • 1[1]Leong KW, Brott BC,Langer R. Bioerodible polyanhydride as drug carrier marices.I:Characterization,degradation. And release characteristics. J Biomed Mater Res, 1985;19:941 被引量:1
  • 2[2]Leon KW, Aomre PD, Marletta M,et al Bioerodible Polyanhydrides as drug carrier matrices Ⅱ: Biocompatibility and chemical reactivity. J Biomed Mater Res, 1986;20(4):51 被引量:1
  • 3[3]Brem H. Polymers to treat brain tumours. Biomaterials, 1990;11(9):699 被引量:1
  • 4[4]Sampath P,Brem H. Implantable slow-release chemotherapeutic polymers for the treatment of malignant brain tumors. Cancer Control,1998;5(2):130 被引量:1
  • 5[5]Bucher JE,Slade WC. The anhydrides of isophthatic and terephthalic acids. J Amer Chem. Soc, 1909;32:1319 被引量:1
  • 6[6]Hill JW, Carothers WH. Studies of polymerization and ring formation XIV; A linear superpolyanhydride and a cyclic dimeric anhydride from sedacic acid. J Amer Chem Soc, 1932; 54:1969 被引量:1
  • 7[7]Conix A. New high-melting fibre-forming polymers. Makromol Chem.1957;24:74 被引量:1
  • 8[8]Yoda N ,Miyake A.Synthesis of polyanhydride,1.Mixed anhydride of aromatic and aliphatic dibasic acids.Makromol Chem,1959;32(10):1120 被引量:1
  • 9[9]Langer R. Biomaterials in drug delivery and tissue engineering. ACC Chem Res,2000;33(2):94 被引量:1
  • 10[10]Domb AJ. Langger R. Polyanhydrides. I. Preparation of high molecular weight polyanhydrides. J Poly Sci,Part A:Polym Chem,1987;25:3373 被引量:1

共引文献9

同被引文献19

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部